San Diego, CA, United States of America

Melinda Ann Lacerte

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melinda Ann Lacerte. Retrieved from https://idiyas.com/inventor/melinda-ann-lacerte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Contributions of Inventor Melinda Ann Lacerte

Introduction: Melinda Ann Lacerte is an accomplished inventor based in San Diego, California. With a passion for innovation in the pharmaceutical industry, she has made significant strides in her field. Her work focuses on the development of compounds that hold promise for therapeutic applications.

Latest Patents: Melinda Ann Lacerte holds one patent titled "GITR antagonists and methods of using the same." This patent relates to compounds that bind to human GITR, featuring pharmaceutical compositions that incorporate these compounds, along with methods for their use. This breakthrough has the potential to impact treatment protocols significantly.

Career Highlights: Currently, Melinda is employed at Eli Lilly and Company, a prominent player in the pharmaceutical sector. Her career is marked by her dedication to advancing medical research and her contributions to innovative therapeutic solutions.

Collaborations: Throughout her career, Melinda has had the opportunity to work alongside esteemed colleagues, including Petra Verdino and Paul Francis Cain. These collaborations demonstrate her ability to engage with other talented individuals in the pursuit of groundbreaking scientific advancements.

Conclusion: Melinda Ann Lacerte's work exemplifies the spirit of innovation within the pharmaceutical field. Her patent and ongoing contributions at Eli Lilly and Company reflect her commitment to improving health outcomes through targeted research and development. As she continues her career, the impact of her inventions will undoubtedly resonate within the scientific community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…